Bioactive Products
A unique collection of 165 natural compounds used for Hepatoprotective research and Hepatoprotective drug screening. | ||
Catalog No: | B36 | Hepatoprotective Compound Library Screening Details |
Size: | 1mg/well * 165 Compounds 2mg/well * 165 Compounds |
Cat. No. | Information |
CFN99085 | Ganodermanondiol Ganodermanondiol exhibits potent cytoprotective effects on t-BHP-induced hepatotoxicity in human liver-derived HepG2 cells, presumably through Nrf2-mediated antioxidant enzymes and AMPK. It also can significantly inhibit the proliferation of leukemic cancer cells, and it could be one of the antileukemie active constituents of Ganoderma lucidum. Ganodermanondiol shows a strong anticomplement activity against the classical pathway (CP) of the complement system with IC(50) values of 41.7 microM. It shows significant anti-human immunodeficiency virus (anti-HIV)-1 protease activity with IC50 values of 20-90 microM. |
CFN99267 | Sculponeatin N Sculponeatin N may have protective effects on the lipid peroxidation-damaged live cells. |
CFN99268 | Sculponeatin O Sculponeatin O may have protective effects on the lipid peroxidation-damaged live cells. |
CFN99270 | Rubiadin Rubiadin has hepatoprotective, antioxidant, and antitumor promoting effects. Rubiadin can decrease bone loss through the inhibition of osteoclast formation,differentiation and bone resorption. |
CFN99278 | Blumeatin Blumeatin has antioxidant properties, free radical scavenging activity,and has xanthine oxidase (XO) inhibitory activity. Blumeatin can protect liver against injury induced by CCl4 and TAA, it can inhibit the increase of serum alanine aminotransferase (AAT) and liver triglyceride and increased serum triglyceride, beta-lipoprotein, and liver glycogen content in CCl4-intoxicated rats, and can shorten the pentobarbital sleeping time in CCl4-intoxicated mice. Blumeatin can promote adipocyte differentiation as characterized by increased triglyceride levels in 3T3L1 cells, also can enhance the accumulation of lipid droplets and induced upregulation of the expression of the adipocyte-specific genes aP2 and GLUT4. |